GNW GENWORTH FINANCIAL INC Insider Trading

GNW CEO McInerney sold 100.0K shares at $9.27; holds 5.37M shares post-sale, down 1.8%

Thomas J McInerney, President and CEO of Genworth Financial, sold 100,000 shares at $9.27 on 2026-05-22 for $927,000.00, reducing his holdings to 5,368,883 shares (a 1.8% reduction). The transaction occurred near the 52-week high of $9.45, with GNW currently trading at $8.84. His prior four sales at GNW have not been well-timed: both measurable outcomes showed positive 90-day returns (+13.0% and +7.1%), meaning the stock rose after he sold, with 0 of 2 prior sales well-timed at the 90-day mark. The company reports steady fundamentals with $1.8B quarterly revenue and a P/E of 15.79, though annual revenue growth is minimal at +0.1%. The sale occurs as a discrete transaction rather than a programmatic pattern and does not materially alter his significant majority stake in the company.

Gupta (CEO, Enact) sold 86.4K shares of GNW at $8.68 on 2025-08-27 (up 8.1% in 30 days)

On August 27, 2025, Rohit Gupta, President & CEO of Enact, sold 86,406 shares at $8.68, reducing his holdings by 9.8% to 794,630 shares and generating $749,865.83. The sale occurred near the 52-week high of $8.68, with the stock up 8.1% over the prior 30 days and 21.6% over 90 days. Gupta's cross-ticker track record shows 1 prior open-market buy (100% win rate over 90 days at +13.7% average return) against 3 prior sells, providing limited historical context specific to GNW for this particular transaction. The company's P/E of 18.63 and annual revenue decline of -2.6% warrant investor attention to underlying business momentum relative to recent stock appreciation.

GNW CEO McInerney sold 150,000 shares at $6.88 on 2024-08-26; stock at current 52-week high, P/E 97.86

McInerney Thomas J, President and CEO, sold 150,000 shares (3.2% of pre-transaction holdings) at $6.88 on 2024-08-26. The transaction occurs at the current 52-week high price of $6.85, with the stock up 10.1% over the past 90 days. Across his prior 4 sales at GNW, McInerney achieved 2 of 4 well-timed outcomes at the 90-day mark, a 50% success rate; most recently, his May 2024 sale saw a 30-day decline of 3.4% and his August 2023 sale declined 8.3% at both 30- and 90-day intervals. Against this context and fundamental backdrop—revenue flat year-over-year at $1.8B and a notably elevated P/E of 97.86—the sale at current highs merits investor attention to near-term price momentum and whether the company can sustain its recent gains.